U.S. Pharma Stock News

Protagonist Therapeutics recently reported a US$44.38 million fourth‑quarter net loss and a full‑year 2025 net loss of US$130.15 million, reversing from profits a year earlier. At the same time, the company advanced its pipeline by submitting an NDA for rusfertide and outlining plans to change its profit‑sharing arrangement with Takeda, signaling a potential shift in how it may capture future economics from this program. With shares rising over the past week, we'll explore how the rusfertide...

Avista (AVA) just posted its full year 2025 results, reporting higher earnings, a 24th consecutive annual dividend increase to US$1.97 per share, and updated guidance along with regulatory and project developments that drew investor attention. See our latest analysis for Avista. At a share price of US$40.62, Avista has seen a 1 day share price return of 2.14% and a year to date share price return of 4.91%. Its 1 year total shareholder return of 6.78% and 5 year total shareholder return of...

Burford Capital (BUR) just reported its Q4 and full-year 2025 results, showing much lower revenue and profitability than a year earlier, and also declared a final dividend that may interest income focused investors. See our latest analysis for Burford Capital. That earnings miss and softer full year profitability appear to be weighing on sentiment. A 7 day share price return of 12.54% and a 30 day share price return of 12.63% have contributed to a 1 year total shareholder return of 45.28%,...

Why Mercury General’s latest earnings matter for investors Mercury General (MCY) just posted fourth quarter and full year 2025 results with higher revenue and net income year over year, alongside a reaffirmed quarterly dividend. This gives investors fresh data on profitability and cash returns. See our latest analysis for Mercury General. Mercury General’s latest results and dividend affirmation have come alongside a 7 day share price return of 4.79% and a softer 90 day share price return of...

Xenon Pharmaceuticals (XENE) is back in focus after reporting wider fourth quarter and full year 2025 losses, followed by a US$400 million at the market follow on equity offering in its common shares. See our latest analysis for Xenon Pharmaceuticals. The US$43.23 share price has seen a mixed stretch, with a 5.41% 1 month share price return and a 2.37% 7 day gain, but a modest year to date decline and recent pressure following the wider losses and US$400 million at the market offering...

Taylor Morrison Home (TMHC) is back in focus after two years of order backlog declines averaging 33.6% year over year and analyst forecasts indicating a 17.2% revenue drop over the coming year. See our latest analysis for Taylor Morrison Home. The share price has held around US$65.89 with a 30 day share price return of 8.11% and a 12.00% year to date share price return. The 5 year total shareholder return of 143.14% highlights how much of the story sits in longer holding periods as current...

Southwest Gas Holdings reported past full-year 2025 results with revenue of US$1,940.38 million and net income of US$439.83 million, while also announcing a 4% increase in its quarterly dividend to US$0.645 per share starting in the second quarter of 2026. Alongside these financial moves, the company completed its shift to a fully regulated natural gas utility and outlined sizeable capital investments and regulatory initiatives that could reshape its earnings profile and shareholder payout...

In February 2026, BKV Corporation reported fourth-quarter 2025 results showing revenue rising to US$330.09 million and net income of US$70.38 million, marking a shift from a loss a year earlier alongside higher natural gas production. The company also advanced its integrated gas, power and carbon capture model, including a US$500 million carbon capture partnership and refreshed CCUS injection targets that deepen its low-carbon energy ambitions. We’ll now explore how BKV’s move to...

Tuya (TUYA) is in focus ahead of its March 2, 2026 quarterly earnings release, as investors watch to see whether the company can meet expectations for $0.03 in earnings per share and provide guidance that supports its outlook. See our latest analysis for Tuya. At a share price of $2.55, Tuya has seen strong near term momentum, with a 1 day share price return of 5.37% and a 30 day share price return of 22.01%. However, its 1 year total shareholder return of 22.17% and 3 year total shareholder...

In recent days, Centessa Pharmaceuticals reported positive Phase 2a progress for its lead orexin receptor agonist ORX750 in narcolepsy and idiopathic hypersomnia, alongside updates on its broader neurology and neuropsychiatry pipeline. This progress, combined with broad analyst support despite the absence of approved products, is sharpening attention on Centessa’s orexin-focused early-stage portfolio and upcoming clinical and regulatory milestones. We’ll now examine how the encouraging...

Veracyte, Inc. recently reported its fourth-quarter and full-year 2025 results, with revenue rising to US$140.64 million in Q4 and US$517.15 million for the year, alongside a jump in net income to US$41.15 million for the quarter and US$66.35 million for 2025. The company reaffirmed its 2026 revenue guidance of US$570 million to US$582 million and highlighted two upcoming cancer diagnostics launches, TRUE MRD for bladder cancer and Prosigna for early-stage breast cancer, as key growth...

Valmont Industries recently approved a 13% increase in its quarterly cash dividend to US$0.77 per share, lifting the annualized payout to US$3.08 and scheduled for payment on April 15, 2026, while also appointing agribusiness executive Paul Maass to its now eleven-member Board of Directors. This combination of a higher cash return and the addition of a director with deep global agriculture and supply chain experience highlights Valmont’s emphasis on aligning capital allocation with sector...

Commercial Metals (CMC) is drawing fresh attention as it heads into its fiscal Q2 2026 earnings release and webcasted conference call, following two recent concrete products acquisitions. See our latest analysis for Commercial Metals. Recent trading has cooled after a strong run, with a 1 day share price return of 2.15% decline and a 30 day share price return of 5.98% decline. However, the 1 year total shareholder return of 53.28% and 5 year total shareholder return of 173.11% point to...

Rush Street Interactive (RSI) is back in focus after reporting fourth quarter and full year 2025 results, with higher sales and net income, and issuing 2026 revenue guidance that signals management confidence in the business. See our latest analysis for Rush Street Interactive. The latest earnings release and 2026 revenue guidance appear to have reinforced interest in Rush Street Interactive, with a 7 day share price return of 6.64% and 30 day share price return of 11.77%, while the 1 year...

In late February 2026, Photronics reported another earnings beat with fiscal first-quarter 2026 revenue of about US$225.1 million and non-GAAP earnings of US$0.61 per share, alongside guidance for second-quarter revenue between US$212 million and US$220 million and earnings of US$0.49 to US$0.55 per share. This performance included record high-end integrated circuit revenue for the second consecutive quarter, supported by ongoing facility expansions in the US and Korea aimed at diversifying...

Pebblebrook Hotel Trust recently reported its fourth-quarter and full-year 2025 results, showing modest revenue growth to US$210.94 million for the quarter and US$1.48 billion for the year, alongside a reduced quarterly net loss and ongoing share repurchases under its existing buyback program. The REIT also issued 2026 guidance indicating it still expects a net loss or only modest net income, underscoring how improving funds from operations and disciplined capital deployment, rather than...

SoundHound AI, Inc. has reported fourth-quarter 2025 sales of US$55.06 million and net income of US$40.06 million, while nearly doubling full-year revenue to US$168.92 million and sharply reducing its annual net loss to US$14.01 million. Alongside these results, the company launched its new Sales Assist retail AI agent and opened an innovation hub in Bengaluru, India, signalling a push to extend its agentic AI platform across more industries and geographies. Next, we’ll examine how this...

Cactus (WHD) is back on investors’ radar after recent trading left the shares at $54. With pressure control and spoolable pipe operations across several regions, the stock’s recent pullback contrasts with its past 3 months’ return. See our latest analysis for Cactus. The recent pullback that left Cactus at a share price of $54 comes after a 90 day share price return of 24.54% and a 5 year total shareholder return of 53.73%. This suggests shorter term momentum has cooled even as longer term...

In late February 2026, Alphatec Holdings, Inc. reported that its fourth-quarter 2025 net loss narrowed to US$21.73 million and full-year net loss improved to US$143.36 million, while reaffirming its 2026 revenue outlook of about US$890 million. Management also highlighted strong surgeon adoption, double-digit surgical volume and revenue growth in 2025, and a goal to generate US$20 million in free cash flow in 2026, underscoring its focus on scaling an integrated spine surgery platform. With...

FirstEnergy Corp. has reported its 2025 results, with revenue rising to US$15.09 billion and net income reaching US$1.02 billion, alongside modestly higher earnings per share from continuing operations. At the same time, the company unveiled its Energize365 program, a US$36 billion capital plan for 2026–2030 that heavily prioritizes transmission upgrades and grid resilience, aiming to support long-term value creation. Next, we'll examine how this expanded US$36 billion Energize365 investment...

In late February 2026, Permian Resources Corporation reported fourth‑quarter 2025 results showing higher production across oil, NGLs, and natural gas, alongside net income of US$339.51 million and quarterly diluted EPS of US$0.45. The company coupled record operational performance and an earnings beat with a 7% increase in its quarterly base dividend to US$0.16 per share, highlighting an emphasis on cost efficiency, acquisitions, and cash returns despite softer revenue. Next, we’ll examine...

In February 2026, Select Water Solutions, Inc. completed a US$175.0 million follow-on offering of 13,725,491 Class A shares at US$12.75 each under a new universal shelf registration, adding to its previously authorized but unused 2024 buyback program and prior completed repurchases. The company has indicated that the fresh equity capital will support general corporate purposes, including expanding its water infrastructure portfolio, potential acquisitions, and possible debt reduction,...

LGI Homes recently announced the past grand opening of Meadow Brook, a 53-home community in Puyallup, Washington, offering three- to five-bedroom single-family and duplex homes with its CompleteHome Plus package and convenient access to nearby Tacoma amenities. The project not only widens LGI Homes’ footprint in the greater Seattle area but also showcases its focus on move-in-ready, upgraded homes in supply-constrained, high-demand markets. We’ll now examine how this expansion of LGI Homes’...

Dentsply Sirona (XRAY) shares have been reacting to a mixed fourth quarter, with a revenue beat and year-on-year sales growth, paired with softer full-year guidance and a 24-month return-to-growth plan. See our latest analysis for DENTSPLY SIRONA. The mixed Q4 and impairment news has arrived alongside a sharp sentiment shift, with a 1 day share price return of 15.5% and a 90 day share price return of 31.31%, even though the 1 year total shareholder return is a 6.96% loss and the 5 year total...